U.S. Markets open in 4 hrs 31 mins

CVS To Pull Curaleaf Products From CBD Offerings After FDA Warning; Marijuana Stocks Fall

BILL PETERS
CVS To Pull Curaleaf Products From CBD Offerings After FDA Warning; Marijuana Stocks Fall

U.S. cannabis producer Curaleaf received a warning letter from the Food and Drug Administration saying several of its hemp CBD products are "unapproved new drugs" running afoul of the law